Those of us involved in the marijuana legalization movement have long assumed that those companies that produce and sell competing products — especially alcohol and tobacco — were working behind the scenes to try to maintain marijuana prohibition and to protect their duopoly for legal recreational drugs. These industries have lobbyists who regularly work with state and federal elected officials to keep legal marijuana off the market. But we now see the pharmaceutical companies are also getting directly involved in political efforts to maintain marijuana prohibition, worried that legal marijuana will undermine their bottom line. Pharmaceutical company joins the war on marijuana smokers. Recently, we saw the first direct evidence that pharmaceutical companies are now working to defeat marijuana legalization…
The NORML board felt the Aransas Medical Cannabis Act is a more consumer-friendly proposal and elected to endorse it.
Meeting at our board meeting in Boston this past Friday, held in conjunction with the Boston Freedom Rally, the national NORML board of Directors endorsed Denver social use Initiative 300, the Neighborhood-Supported Cannabis Consumption Pilot Program.
Either we offer a legal option for marijuana-friendly lounges, or “smoke-easies” will continue to proliferate in most major cities.
The four states and the District of Columbia that have approved full legalization for all adults, and the five states that will be voting on full legalization in November, all rely on voter initiatives. These progressive procedures have worked precisely as they were intended back in the Progressive Era: They have allowed citizens to go around the establishment to alter the status quo.
Drug use and abuse is worldwide, so the solution to the destructive war on drug users must also be worldwide.
Just as all states now have some form of legal gambling, within a few short years, all states will offer some form of legal marijuana. It’s the smart thing to do; it’s the right thing to do; and it’s inevitable in a democracy, when most people want it.
A three-judge panel of the US Court of Appeals for the 9th Circuit, covering nine western states, earlier this week ruled unanimously that the Department of Justice is barred by federal law from prosecuting medical marijuana businesses if those businesses are operating in compliance with state law.
In fact, what Congress should really do, and what NORML has been arguing for some time, is to totally de-schedule marijuana by removing it from the Controlled Substances Act and treat it as we do alcohol and tobacco, thus providing states the power to establish their own marijuana regulatory policies free from federal interference.
Which raises the obvious question: how is the legalization of marijuana continuing to move forward politically in more and more states if only one out of 8 Americans are current users? The answer: you don’t have to be a marijuana smokers to oppose prohibition.